Treatment

lurbinectedin, JEMPERLI 500 mg concentrate for solution for infusion clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingPhase I and Phase II (Integrated)- Other
Phase I-II Study to Assess the Safety, Tolerability and Efficacy of Lurbinectedin and Dostarlimab in Advanced/Recurrent Endometrial Cancer Patients with Disease Progression after Prior Therapy with Platinum-based Chemotherapy. LiDer trial
This study is looking at a new combination treatment for advanced womb cancer that has come back or spread after previous chemotherapy. It aims to see how safe and effective lurbinectedin and dostarlimab are together in hopefully shrinking tumours.
For: Advanced/Recurrent Endometrial Cancer Patients with Disease Progression after Prior Therapy with Platinum-based Chemotherapy
Spain